CD40-activated B cells contribute to mesothelioma tumor regression. - Wikidata - awgldk - TriplyDB

CD40-activated B cells contribute to mesothelioma tumor regression.

CD40-activated B cells contribute to mesothelioma tumor regression.

http://www.wikidata.org/entity/Q43406455

about

Positive and negative functions of B lymphocytes in tumors The "Trojan Horse" approach to tumor immunotherapy: targeting the tumor microenvironment.Characterization of tumor-associated B-cell subsets in patients with colorectal cancer.Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy Multivalent porous silicon nanoparticles enhance the immune activation potency of agonistic CD40 antibody.Human mesothelioma induces defects in dendritic cell numbers and antigen-processing function which predict survival outcomes Murine mesothelioma induces locally-proliferating IL-10(+)TNF-α(+)CD206(-)CX3CR1(+) M3 macrophages that can be selectively depleted by chemotherapy or immunotherapy.Identification of IFN-γ-producing innate B cells The use of agonistic anti-CD40 therapy in treatments for cancer.T-cell-independent antitumor effects of CD40 ligation.Manipulation of tumour-infiltrating B cells and tertiary lymphoid structures: a novel anti-cancer treatment avenue?Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8(+) T cells in vivo.Intratumoral interleukin-2/agonist CD40 antibody drives CD4+ -independent resolution of treated-tumors and CD4+ -dependent systemic and memory responses.Turning the tumor microenvironment into a self vaccine site.Th1 cytokines are more effective than Th2 cytokines at licensing anti-tumour functions in CD40-activated human macrophages in vitro.The Use of Anti-CD40 mAb in Cancer.Bispecific antibodies in cancer immunotherapy

P2860

Q26743398-C188DA63-DA73-4463-AA28-C1EEE1E768F5 Q33736218-498CB6A3-4993-4587-AD19-FE9D9604431A Q34103969-3F19767A-3D3D-4B03-9431-0AB0DAF955B4 Q35119800-F6AC929E-614C-4266-8C70-6768A3D8D3CC Q36452648-34F2043A-F3EE-424A-8774-BAD7B647E94D Q36711060-7496FFDF-57F3-4AC5-9E0A-0B577C67F05D Q37078960-9B102C2B-561E-4F9D-8E0C-543A4A346731 Q37561644-8103CF5E-E314-4271-895A-DEBE7FCFB9AD Q38026924-07D5FB66-F4E0-47E9-8E97-CFEB6C0BFF68 Q38026925-02E233B6-C7EA-4898-8F3D-EF5C469CDEBC Q38201655-38042D2B-5078-4B83-8F80-83CF742DD2BE Q39328222-929D6328-625E-4FBA-B264-0FB6BC6405AC Q39457393-9974FFE3-2626-4A5C-B4C2-F203682EC442 Q41474502-C91BE2D8-E14B-4F87-AD3D-9B2E580EBD2A Q43428464-B844E367-9512-483D-AB56-0B822984EAE1 Q53321210-9638908C-157B-4386-9701-E274D9EB0568 Q56893015-2DFB5135-F36F-4FD3-9DB3-A12505455A75

P2860

CD40-activated B cells contribute to mesothelioma tumor regression.

http://www.wikidata.org/entity/Q43406455

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

CD40-activated B cells contribute to mesothelioma tumor regression.

@en

CD40-activated B cells contribute to mesothelioma tumor regression.

@nl

type

label

CD40-activated B cells contribute to mesothelioma tumor regression.

@en

CD40-activated B cells contribute to mesothelioma tumor regression.

@nl

prefLabel

CD40-activated B cells contribute to mesothelioma tumor regression.

@en

CD40-activated B cells contribute to mesothelioma tumor regression.

@nl

P1433

Q43406455-F22C5878-19CB-481B-93B5-428A4B402937

P1476

Q43406455-59556583-E1A7-4482-8E0B-8B56EA6EA0B2

P2093

Q43406455-103E5527-5224-44F7-989F-C0B72334B90A

Q43406455-5564ADC7-B473-47CB-ADB9-5752A0E61109

P2860

Q43406455-0F8A8B38-D773-42FD-8CD0-C90521E125E1

Q43406455-1176BE2E-F055-410E-96A8-7236C5A75177

Q43406455-1636EC5B-DC36-4B4D-96E8-05F8FDFA430C

Q43406455-1FB987A7-3AB3-4A18-99BA-E548535E0EF4

Q43406455-329659F2-8474-4214-BFF9-AFF8818AB6AB

Q43406455-3CA77EBB-517F-449F-9F78-842988A4819A

Q43406455-4174AFA6-74E8-4A38-A402-6297CFA74A83

Q43406455-4AF18BEA-232E-4E9A-9E62-122F3BCC3235

Q43406455-51769A1F-95AF-464C-BE32-E11AE291275E

Q43406455-53152D6D-2F24-4FBA-BBCD-294ED9878CB9

P304

Q43406455-AA6678EE-0211-43B6-97A3-2D7F46ECC1DD

P31

Q43406455-AEB8B4BD-CE50-4D01-AFCB-12675E7AB980

P356

Q43406455-185163D1-CB31-4A77-AD93-45A47B283F8F

P433

Q43406455-B8CDC1C4-6A17-431D-A0A4-D829743F57DD

P478

Q43406455-06821AFA-D494-4CD3-8F79-DA20667F0DF2

P50

Q43406455-69E85944-12D4-46F5-864B-6215EE3C43FE

Q43406455-8F52A803-62FE-4FF8-9D1C-1AE9D07BFEDA

P577

Q43406455-A5915908-2078-4EB9-8FCB-FF3492444F24

P698

Q43406455-C85E27EE-595E-4073-BCD6-DDE8B78204BD

P356

P1433

Immunology & Cell Biology

P1476

CD40-activated B cells contribute to mesothelioma tumor regression

@en

P2093

Peter Thomas Graham

http://www.w3.org/2001/XMLSchema#string

Scott Cornwall

http://www.w3.org/2001/XMLSchema#string

P2860

Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines

Determination of lymphocyte division by flow cytometry

Serologic responses in patients with malignant mesothelioma: evidence for both public and private specificities.

B cell immunopoiesis: visualizing the impact of CD40 engagement on the course of T cell-independent immune responses in an Ig transgenic system

CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunity.

Immunological enhancement of primary tumor development and its prevention.

Plasma cells: finding new light at the end of B cell development.

Gene therapy of mesothelioma.

B-1 B cell development.

Humoral immunity, inflammation and cancer.

P304

255-267

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ICB.2010.88

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P50

Delia J. Nelson

Connie Jackaman

P577

2010-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20628372

http://www.w3.org/2001/XMLSchema#string